Article info

Download PDFPDF

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis

Authors

  • Michael Lattanzi Department of MedicineNYU Langone Health New York NY USA Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Joseph Han Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Una Moran Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA Ronald O. Perelman Department of DermatologyNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Kierstin Utter Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA Ronald O. Perelman Department of DermatologyNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Jeremy Tchack Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA Ronald O. Perelman Department of DermatologyNYU Langone Health New York NY USA PubMed articlesGoogle scholar articles
  • Rachel Lubong Sabado Department of MedicineIcahn School of Medicine at Mount Sinai New York NY USA Tisch Cancer InstituteIcahn School of Medicine at Mount Sinai New York NY USA PubMed articlesGoogle scholar articles
  • Russell Berman Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA Department of SurgeryNYU Langone Health New York NY USA Laura and Isaac Perlmutter Cancer CenterNYU Langone Health 160 East 34th Street, 9N Floor 10016 New York NY USA PubMed articlesGoogle scholar articles
  • Richard Shapiro Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA Department of SurgeryNYU Langone Health New York NY USA Laura and Isaac Perlmutter Cancer CenterNYU Langone Health 160 East 34th Street, 9N Floor 10016 New York NY USA PubMed articlesGoogle scholar articles
  • Hsin-Hui Huang Institute for Health Care Delivery ScienceIcahn School of Medicine at Mount Sinai New York NY USA PubMed articlesGoogle scholar articles
  • Iman Osman Department of MedicineNYU Langone Health New York NY USA Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA Ronald O. Perelman Department of DermatologyNYU Langone Health New York NY USA Laura and Isaac Perlmutter Cancer CenterNYU Langone Health 160 East 34th Street, 9N Floor 10016 New York NY USA PubMed articlesGoogle scholar articles
  • Nina Bhardwaj Department of MedicineIcahn School of Medicine at Mount Sinai New York NY USA Tisch Cancer InstituteIcahn School of Medicine at Mount Sinai New York NY USA Parker Institute for Cancer Immunotherapy, Extramural Member New York NY USA PubMed articlesGoogle scholar articles
  • Anna C. Pavlick Department of MedicineNYU Langone Health New York NY USA Interdisciplinary Melanoma Cooperative GroupNYU Langone Health New York NY USA Ronald O. Perelman Department of DermatologyNYU Langone Health New York NY USA Laura and Isaac Perlmutter Cancer CenterNYU Langone Health 160 East 34th Street, 9N Floor 10016 New York NY USA PubMed articlesGoogle scholar articles
  1. a Michael.Lattanzi{at}nyumc.org
  2. b Joseph.Han{at}med.nyu.edu
  3. c Una.Moran{at}nyumc.org
  4. d Kierstin.Utter{at}gmail.com
  5. e jtchack11{at}gmail.com
  6. f Rachel.Sabado{at}mssm.edu
  7. g Russell.Berman{at}nyumc.org
  8. h Richard.Shapiro{at}nyumc.org
  9. i Hsinhui.Huang{at}gmail.com
  10. j Iman.Osman{at}nyumc.org
  11. k Nina.Bhardwaj{at}mssm.edu
  12. l Anna.Pavlick{at}nyumc.org
View Full Text

Citation

Lattanzi M, Han J, Moran U, et al
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis

Publication history

  • Received December 27, 2017
  • Accepted February 13, 2018
  • First published May 18, 2018.
Online issue publication 
May 18, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.